发明名称 Mucin antigen vaccine
摘要 Provided are expression vectors for generating an immune response to a mucin. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal, a mucin antigen and CD40 ligand. Also provided are methods of generating an immune response against cells expressing a mucin by administering an effective amount of the vector. Further provided are methods of generating an immune response against cancer cells expressing a mucin in an individual by administering an effective amount of the vector. Still further provided are methods of overcoming anergy to a mucin self antigen by administering an effective amount of the vector.
申请公布号 US9402920(B2) 申请公布日期 2016.08.02
申请号 US201414256091 申请日期 2014.04.18
申请人 MicroVAX, LLC 发明人 Tang Yucheng;Deisseroth Albert
分类号 A61K48/00;A61K39/00;C07K14/47;C07K14/705;C12N15/85;A61K9/127 主分类号 A61K48/00
代理机构 代理人 Frank Jacob;Snyder Glenn
主权项 1. An expression vector for generating in an individual immunity against a mucin antigen, said vector comprising a transcription unit encoding a polypeptide, said encoded polypeptide comprising from the amino terminus, a secretory signal sequence, the mucin antigen, and CD40 ligand, wherein (i) the mucin antigen does not include a transmembrane domain; (ii) the CD40 ligand does not include a transmembrane domain; (iii) the mucin antigen is attached to the amino terminus of the extracellular domain of said CD40 ligand; and (iv) said encoded polypeptide is configured to promote presentation of Class I MHC and activation with expansion of mucin specific Class I MHC restricted cytotoxic lymphocytes.
地址 Warrenton VA US